FTC to block Amgen's deal to acquire Horizon - source
May 15 (Reuters) - The US Federal Trade Commission (FTC) is expected to file a lawsuit as early as Tuesday to block Amgen Inc's AMGN.O deal to buy Horizon Therapeutics PLC HZNP.O , a person familiar with the matter told Reuters on Monday. (Reporting by Akanksha Khushi in Bengaluru and Diane Bartz; Editing by Sherry Jacob-Phillips) ((Akanksha.Khushi@thomsonreuters.com;))
Recent news on Horizon Therapeutics
See all newsDeals of the day-Mergers and acquisitions
Amgen completes $27.8 bln Horizon deal (updated)
Amgen completes acquisition of Horizon Therapeutics
Brief: Amgen Completes Acquisition Of Horizon Therapeutics PLC
On October 5, Court Sanctioned The Scheme Of Arrangement Under Chapter 1 Of Part 9 Of The Irish Companies Act 2014